Autologous CAR T cells targeting B7-H3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CAR T cells targeting B7-H3, covering 2025-12-22 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian [Phase 1]